Medical Journals Mull Hedge Fund Disclosures

Jan 20 2011 | 2:59am ET

More than a dozen top medical research journals are to consider requiring authors to disclose payments from hedge funds and other investment firms.

The move by the New England Journal of Medicine, Journal of the American Medical Association, The Lancet and 11 other publications follows the arrest of a doctor for allegedly passing confidential information about a drug trial to hedge fund FrontPoint Partners. Yves Benhamou was an adviser to the drug market, Human Genome Sciences, as well as to several hedge funds.

The 14 members of the International Committee of Medical Journal Editors will discuss a possible disclosure requirement at their annual meeting in June. Researchers are already required to disclose financial relationships with drug and medical device makers.

Medical journals are scoured by health-care investors, and articles can have a major impact on the market.


In Depth

Kettera Q&A: The Advantages of Alternative Investment Platforms

Oct 28 2016 | 5:52pm ET

The past several years have seen a distinct push towards easier and cheaper access...

Lifestyle

Midtown's Plaza District Fades As Manhattan Office Landscape Shifts

Nov 22 2016 | 6:32pm ET

Lower leasing costs, more efficient office space and the hope of projecting an image...

Guest Contributor

Nowhere to Hide: Why the Future of Asset Management Depends on Innovation

Nov 15 2016 | 6:55pm ET

Information technology has reshaped the asset management industry’s periphery,...

 

From the current issue of

Chicago-based independent futures brokerage and clearing firm R.J. O’Brien & Associates (RJO) has hired industry veteran Daniel Staniford as Executive Director, responsible for the firm’s institutional business development in New York and London.

AVAILABLE NOW at BARNES & NOBLE

NEWSTAND LOCATOR